ANTM Share Price | Elevance Health, Inc. Stock Analysis & Recommendation

Q: How big is Elevance Health, Inc.?

Market Cap: As of Jun 18, Elevance Health, Inc. has a market capitalization of 84,768.40 million, categorizing it as a Large Cap company.Recent Quarterly Performance: For the latest four quarters, Elevance Health, Inc. reported net sales of 0.00 million and a net profit of 5,906.00 million.Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 41,315.00 million and total assets of 116,889.00 million.

Q: What does Elevance Health, Inc. do?

Overview:Elevance Health, Inc. is a health benefits company operating in the Healthcare Services industry with a large market capitalization.Financial Snapshot:Most recent Net Profit: 2,184 Million (Quarterly Results - Mar 2025)Market cap: USD 84,768.40 Million (Large Cap)Key Metrics:P/E: 15.00Dividend Yield: 141.81%Debt Equity: -0.09Return on Equity: 13.90%Price to Book: 1.99Contact Details:Address: 220 Virginia Avenue, INDIANAPOLIS IN: 46204Tel: 1 317 4886000Website: https://www.antheminc.com/

Q: Is Elevance Health, Inc. overvalued or undervalued?

As of 31 July 2025, the valuation grade for Elevance Health, Inc. has moved from very expensive to expensive, indicating a slight improvement but still suggesting that the stock is not attractively priced. Based on the current metrics, Elevance Health appears to be overvalued. The P/E ratio stands at 15, while its peers, such as UnitedHealth Group, Inc. and The Cigna Group, have P/E ratios of 13.13 and 15.76, respectively, indicating that Elevance Health's valuation is higher than some of its competitors. Additionally, the EV to EBITDA ratio is notably high at 59.39, further supporting the overvaluation thesis.In terms of recent performance, Elevance Health has underperformed compared to the S&P 500, with a year-to-date return of -14.40% versus the S&P 500's 12.22%. This trend continues over longer periods, with a 1-year return of -41.47% compared to the S&P 500's 17.14%, and a 3-year return of -34.25% against the S&P 500's 70.41%. These figures reinforce the notion that Elevance Health is currently overvalued in the market.

Q: Is Elevance Health, Inc. technically bullish or bearish?

As of 3 October 2025, the technical trend for Elevance Health, Inc. has changed from mildly bearish to sideways. The current technical stance is neutral, with mixed indicators. The weekly MACD is mildly bullish, while the monthly MACD is bearish. The weekly RSI shows no signal, but the monthly RSI is bullish. Moving averages indicate a mildly bearish trend on the daily timeframe. The stock has outperformed the S&P 500 over the past week and month, returning 9.46% and 11.57% respectively, but has underperformed over longer periods, with a 1-year return of -28.88% compared to the S&P 500's 17.82%. Overall, the mixed signals suggest caution in the current market environment.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

2.39 M

Shareholding (Dec 2025)

FII

21.44%

Held by 578 FIIs

DII

41.32%

Held by 62 DIIs

Promoter

0.35%

How big is Elevance Health, Inc.?

22-Jun-2025

As of Jun 18, Elevance Health, Inc. has a market capitalization of $84.77 billion, with net sales of $0 million and a net profit of $5.91 billion over the latest four quarters. The company reported shareholder's funds of $41.32 billion and total assets of $116.89 billion as of Dec 24.

View full answer

What does Elevance Health, Inc. do?

22-Jun-2025

Elevance Health, Inc. is a health benefits company with a market cap of approximately $84.77 billion, reporting a net profit of $2.18 billion in Q1 2025. Key metrics include a P/E ratio of 15.00 and a dividend yield of 141.81%.

View full answer

Who are in the management team of Elevance Health, Inc.?

22-Jun-2025

As of March 2022, the management team of Elevance Health, Inc. includes Independent Chairman Ms. Elizabeth Tallett, CEO Ms. Gail Boudreaux, and several Independent Directors: Mr. R. Kerry Clark, Mr. Robert Dixon, Mr. Lewis Hay, Ms. Julie Hill, and Dr. Bahija Jallal. They are responsible for the company's strategic direction and governance.

View full answer

Is Elevance Health, Inc. overvalued or undervalued?

20-Sep-2025

As of July 31, 2025, Elevance Health, Inc. is considered overvalued with a P/E ratio of 15 compared to its peers and has underperformed the S&P 500 significantly, with year-to-date returns of -14.40% and a 1-year return of -41.47%.

View full answer

Is Elevance Health, Inc. technically bullish or bearish?

07-Oct-2025

As of October 3, 2025, Elevance Health, Inc. shows a neutral technical trend with mixed indicators, including a mildly bullish weekly MACD and a bearish monthly MACD, while outperforming the S&P 500 recently but underperforming over the past year, suggesting caution in the current market.

View full answer

Compare Elevance Health, Inc. with Similar Stocks

UnitedHealth Group, Inc.The Cigna Group Humana, Inc.

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 14.83%

Poor long term growth as Operating profit has grown by an annual rate of -306.99%

Flat results in Jun 25

With ROE of 13.90%, it has a expensive valuation with a 2.09 Price to Book Value

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Healthcare Services

Market cap

USD 64,461 Million (Large Cap)

P/E

11.00

Industry P/E

Dividend Yield

2.42%

Debt Equity

-0.09

Return on Equity

12.90%

Price to Book

1.47

Revenue and Profits:

Net Sales:

(Quarterly Results - Dec 2025)

Net Profit:

546 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

-15.41%

6 Months

-7.69%

1 Year

-33.19%

2 Years

-42.99%

3 Years

-37.07%

4 Years

-39.02%

5 Years

-17.5%

Elevance Health, Inc. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

10.32%

EBIT Growth (5y)

EBIT to Interest (avg)

0.04

Debt to EBITDA (avg)

19.11

Net Debt to Equity (avg)

0.69

Sales to Capital Employed (avg)

2.55

Tax Ratio

24.32%

Dividend Payout Ratio

27.13%

Pledged Shares

Institutional Holding

95.49%

ROCE (avg)

0.14%

ROE (avg)

14.83%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.47

EV to EBIT

EV to EBITDA

39.15

EV to Capital Employed

1.52

EV to Sales

0.30

PEG Ratio

Dividend Yield

2.42%

ROCE (Latest)

ROE (Latest)

12.90%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

RSI

No Signal

Bollinger Bands

Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

OBV

Mildly Bullish

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Dec 2025

Shareholding Compare (%holding)

Majority shareholders

Domestic Funds

Held in 208 Schemes (36.88%)

Foreign Institutions

Held by 578 Foreign Institutions (21.44%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -54.00% vs -31.94% in Sep 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "406.00",
          "val2": "387.00",
          "chgp": "4.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "366.00",
          "val2": "351.00",
          "chgp": "4.27%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "546.00",
          "val2": "1,187.00",
          "chgp": "-54.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "11.70%",
          "val2": "34.60%",
          "chgp": "-2.29%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -5.19% vs -0.33% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,546.00",
          "val2": "1,393.00",
          "chgp": "10.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "1,402.00",
          "val2": "1,185.00",
          "chgp": "18.31%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "5,661.00",
          "val2": "5,971.00",
          "chgp": "-5.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "40.70%",
          "val2": "50.30%",
          "chgp": "-0.96%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ

Dec'25

Sep'25

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

406.00

387.00

4.91%

Interest

366.00

351.00

4.27%

Exceptional Items

0.00

Consolidate Net Profit

546.00

1,187.00

-54.00%

Operating Profit Margin (Excl OI)

11.70%

34.60%

-2.29%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Dec 2025 is 0.00% vs 0.00% in Sep 2025

Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -54.00% vs -31.94% in Sep 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

1,546.00

1,393.00

10.98%

Interest

1,402.00

1,185.00

18.31%

Exceptional Items

0.00

Consolidate Net Profit

5,661.00

5,971.00

-5.19%

Operating Profit Margin (Excl OI)

40.70%

50.30%

-0.96%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -5.19% vs -0.33% in Dec 2024

All Annual Results

Company CV

About Elevance Health, Inc.

Elevance Health, Inc.

Healthcare Services

Anthem, Inc. is a health benefits company. The Company operates through three segments: Commercial and Specialty Business, Government Business and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans; indemnity plans and other hybrid plans, including consumer-driven health plans; and hospital only and limited benefit products. It also provides an array of managed care services to self-funded customers, including claims processing, underwriting, stop loss insurance, actuarial services, provider network access, medical cost management, disease management, wellness programs and other administrative services. It provides an array of specialty and other insurance products and services, such as dental, vision, life and disability insurance benefits and radiology benefit management.

Company Coordinates

Company Details

220 Virginia Avenue , INDIANAPOLIS IN : 46204

Tel: 1 317 4886000

https://www.antheminc.com/

Registrar Details